C12N 2506/13
From connective tissue cells, from mesenchymal cells
Official title: from connective tissue cells, from mesenchymal cells
C12N2506/13 (From connective tissue cells, from mesenchymal cells) appears on 737 US grants and 1,571 published applications in this corpus.
Search patents in C12N- Granted patents
- 737
- Published applications
- 1,571
- Assignees
- 727
- Inventors
- 2,740
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 2 |
| 2002 | 4 | 8 |
| 2003 | 2 | 20 |
| 2004 | 2 | 22 |
| 2005 | 2 | 26 |
| 2006 | 7 | 26 |
| 2007 | 9 | 27 |
| 2008 | 5 | 22 |
| 2009 | 10 | 35 |
| 2010 | 13 | 41 |
| 2011 | 13 | 42 |
| 2012 | 18 | 66 |
| 2013 | 12 | 75 |
| 2014 | 32 | 68 |
| 2015 | 40 | 96 |
| 2016 | 58 | 105 |
| 2017 | 55 | 100 |
| 2018 | 74 | 97 |
| 2019 | 73 | 103 |
| 2020 | 57 | 84 |
| 2021 | 51 | 84 |
| 2022 | 45 | 103 |
| 2023 | 40 | 84 |
| 2024 | 41 | 94 |
| 2025 | 42 | 83 |
| 2026 | 30 | 58 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2506/1346From mesenchymal stem cellsIndexing code421
- C12N 2506/1307From adult fibroblastsIndexing code285
- C12N 2506/1323From skeletal muscle cellsIndexing code18
- C12N 2506/1315From cardiomyocytesIndexing code14
- C12N 2506/1338From smooth muscle cellsIndexing code4
- C12N 2506/133From tenocytesIndexing code0
Recent patents
- Composition for inducing direct cross differentiation of somatic cell into motor neuron, and method for using same6 Oct 2026US 12,753,385 B2Unist (Ulsan National Institute of Science and Technology)
- Composition for enhancing reprogramming efficiency from somatic cell to induced pluripotent stem cell, comprising mTOR activator, and method for enhancing reprogramming efficiency by using same6 Oct 2026US 12,753,394 B2Korea University Research and Business Foundation
- Method for the in vitro or ex vivo amplification of human adipose tissue stem cells1 Sep 2026US 12,723,234 B2Centre National de la Recherche Scientifique (CNRS)
- Satellite cells and compositions and methods for producing the same25 Aug 2026US 12,716,056 B2President and Fellows of Harvard College
- Methods for reprogramming cells30 Jun 2026US 12,668,775 B2Monash University
- Retinal pigment epithelium cell therapy8 Oct 2026US 2026/0306548 A1The Regents of the University of California
- Application of stem cells or transgenic stem cells8 Oct 2026US 2026/0306716 A1Anhui Longhui Stem Cell Biotechnology Co., Ltd
- Composition for inducing dendritic cell differentiation, comprising metal-organic framework, and use thereof8 Oct 2026US 2026/0308523 A1Mediark Inc.
- Xeno-free and transgene-free reprograming of mesenchymal stem cells toward neural progenitor cells1 Oct 2026US 2026/0297516 A1
- Oct3/4 protein variants, and method for producing induced pluripotent stem cells1 Oct 2026US 2026/0297535 A1Riken
Most cited
By later US patents
- Adipose-derived stem cells and lattices313US 6,777,231 B1The Regents of the University of California · 2004
- Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair304US 6,429,013 B1Artecel Science, Inc. · 2002
- Method for processing and using adipose-derived stem cells142US 7,595,043 B2Cytori Therapeutics, Inc. · 2009
- Self-contained adipose derived stem cell processing unit140US 7,390,484 B2Cytori Therapeutics, Inc. · 2008
- Differentiation of adipose stromal cells into osteoblasts and uses thereof129US 6,391,297 B1Artecel Sciences, Inc. · 2002